Ventana Medical Systems Schedules First Quarter 2001 Conference Call

Apr 16, 2001, 01:00 ET from Ventana Medical Systems, Inc.

    TUCSON, Ariz., April 16 /PRNewswire/ -- Ventana Medical Systems, Inc.
 (Nasdaq: VMSI), a leading supplier of automated instrument reagent systems to
 histology labs and drug discovery labs worldwide, today announced that it will
 hold a conference call on Friday, April 20, 2001, at 9:00 a.m. (ET) to discuss
 its first quarter financial and operating results.  The call can be accessed
 via the Internet live and as a replay at http://www.vcall.com .  The webcast
 will be available for replay for a period of 30 days.
     Ventana develops, manufactures and markets instrument/reagent systems that
 automate tissue preparation and slide staining in clinical histology and drug
 discovery laboratories worldwide.  Ventana's clinical systems are important
 tools used in the diagnosis and treatment of cancer and infectious diseases.
 Ventana's drug discovery systems are used to accelerate the discovery of new
 drug targets and evaluate the safety of new drug compounds.
     For more information on Ventana Medical Systems, Inc. via facsimile at no
 additional cost, simply dial 1-800-PRO-INFO and enter the stock symbol "VMSI."
 
     Visit the Ventana Medical Systems, Inc. website at
 http://www.ventanamed.com .
     The Molecular Discovery Systems Division has its own website
 at http://www.ventanadiscovery.com .
 
 

SOURCE Ventana Medical Systems, Inc.
    TUCSON, Ariz., April 16 /PRNewswire/ -- Ventana Medical Systems, Inc.
 (Nasdaq: VMSI), a leading supplier of automated instrument reagent systems to
 histology labs and drug discovery labs worldwide, today announced that it will
 hold a conference call on Friday, April 20, 2001, at 9:00 a.m. (ET) to discuss
 its first quarter financial and operating results.  The call can be accessed
 via the Internet live and as a replay at http://www.vcall.com .  The webcast
 will be available for replay for a period of 30 days.
     Ventana develops, manufactures and markets instrument/reagent systems that
 automate tissue preparation and slide staining in clinical histology and drug
 discovery laboratories worldwide.  Ventana's clinical systems are important
 tools used in the diagnosis and treatment of cancer and infectious diseases.
 Ventana's drug discovery systems are used to accelerate the discovery of new
 drug targets and evaluate the safety of new drug compounds.
     For more information on Ventana Medical Systems, Inc. via facsimile at no
 additional cost, simply dial 1-800-PRO-INFO and enter the stock symbol "VMSI."
 
     Visit the Ventana Medical Systems, Inc. website at
 http://www.ventanamed.com .
     The Molecular Discovery Systems Division has its own website
 at http://www.ventanadiscovery.com .
 
 SOURCE  Ventana Medical Systems, Inc.